These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 22463053)

  • 1. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
    Khan MN; Kaur R; Pichichero ME
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children.
    Pichichero ME; Kaur R; Casey JR; Sabirov A; Khan MN; Almudevar A
    Vaccine; 2010 Oct; 28(44):7184-92. PubMed ID: 20800701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children.
    Kaur R; Casey JR; Pichichero ME
    Vaccine; 2011 Jan; 29(5):1023-8. PubMed ID: 21129398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats.
    Akkoyunlu M; Forsgren A
    APMIS; 1996 Oct; 104(10):709-17. PubMed ID: 8980621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.
    Hua CZ; Hu WL; Shang SQ; Li JP; Hong LQ; Yan J
    Clin Vaccine Immunol; 2016 Feb; 23(2):155-61. PubMed ID: 26677200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
    Bertot GM; Becker PD; Guzmán CA; Grinstein S
    J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody against Haemophilus influenzae protein D in patients with chronic conditions causing secondary immunodeficiency.
    Hawdon N; Biman B; McCready W; Brigden M; Malik S; Vergidis D; Kisselgoff O; Ulanova M
    Vaccine; 2012 Feb; 30(7):1235-8. PubMed ID: 22230580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6.
    Sabirov A; Casey JR; Murphy TF; Pichichero ME
    Pediatr Res; 2009 Nov; 66(5):565-70. PubMed ID: 19581824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
    Forsgren A; Riesbeck K; Janson H
    Clin Infect Dis; 2008 Mar; 46(5):726-31. PubMed ID: 18230042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
    Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME
    J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
    Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental recurrent otitis media induced by Haemophilus influenzae: protection and serum antibodies.
    Melhus A; Hermansson A; Akkoyunlu M; Forsgren A; Prellner K
    Am J Otolaryngol; 1995; 16(6):383-90. PubMed ID: 8572254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children.
    Yamanaka N; Faden H
    J Pediatr; 1993 Feb; 122(2):212-8. PubMed ID: 8429433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilus influenzae-protein D specific antibody correlate with protection against acute otitis media in young children.
    Almudevar A; Pichichero ME
    Vaccine; 2018 Feb; 36(9):1133-1135. PubMed ID: 29395516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidation of
    Kaur R; Pichichero M
    Infect Immun; 2022 May; 90(5):e0067821. PubMed ID: 35435727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
    Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
    Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens.
    Thornton RB; Kirkham LS; Corscadden KJ; Wiertsema SP; Fuery A; Jones BJ; Coates HL; Vijayasekaran S; Zhang G; Keil A; Richmond PC
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28151410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media.
    DeMaria TF; Murwin DM; Leake ER
    Infect Immun; 1996 Dec; 64(12):5187-92. PubMed ID: 8945564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.
    Clarke C; Bakaletz LO; Ruiz-Guiñazú J; Borys D; Mrkvan T
    Expert Rev Vaccines; 2017 Jul; 16(7):1-14. PubMed ID: 28571504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mouse macrophage-derived chemokine as an adjuvant enhances the protective effect of P6 protein vaccine of nontypeable Haemophilus influenzae].
    Han X; Wang C; Qiao H; Zhang Y; Chang Y; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):913-6. PubMed ID: 25200152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.